{"date":"2025-11-06","count":60,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4129-2025-11-06-2058-1gzzgpm","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"20:58:16","subject":"公告本公司修訂國內第五次無擔保轉換公司債發行及轉換辦法之債權人公告","clause":"第53款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-11-06 20:58，「公告本公司修訂國內第五次無擔保轉換公司債發行及轉換辦法之債權人公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2025-11-06-2058-1evbpk8","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"20:58:01","subject":"公告本公司修訂國內第五次無擔保轉換公司債發行及轉換辦法","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-11-06 20:58，「公告本公司修訂國內第五次無擔保轉換公司債發行及轉換辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2025-11-06-2057-1xfuutk","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"20:57:44","subject":"公告本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-11-06 20:57，「公告本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2025-11-06-2057-isqttc","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"20:57:21","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-11-06 20:57，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-11-06-2047-1jm43nd","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-11-06","time":"20:47:13","subject":"公告本公司取得會計師內部控制專案審查報告","clause":"第25款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-11-06 20:47，「公告本公司取得會計師內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-11-06-1847-1j4f2tm","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"18:47:27","subject":"依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告","clause":"第22款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-11-06 18:47，「依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-11-06-1847-1wtif9w","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"18:47:15","subject":"代子公司MKHM 依公開發行公司資金貸與及背書保證處理準則第22條第1項第2款及第3款公告","clause":"第23款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-11-06 18:47，「代子公司MKHM 依公開發行公司資金貸與及背書保證處理準則第22條第1項第2款及第3款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-11-06-1847-1pi1gre","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"18:47:04","subject":"依公開發行公司資金貸與及背書保證處理準則 第22條第1項第3款公告","clause":"第23款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-11-06 18:47，「依公開發行公司資金貸與及背書保證處理準則 第22條第1項第3款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-11-06-1846-1skm07g","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"18:46:52","subject":"公告本公司董事會決議114年第二次私募普通股定價相關事宜","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-11-06 18:46，「公告本公司董事會決議114年第二次私募普通股定價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-11-06-1844-1fraips","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"18:44:53","subject":"公告本公司董事會通過114年第三季合併財務報告案","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-11-06 18:44，「公告本公司董事會通過114年第三季合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2025-11-06-1842-1oq1jp9","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"18:42:26","subject":"公告本公司董事會決議通過更換股務代理機構事宜","clause":"第53款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：天良（4127），2025-11-06 18:42，「公告本公司董事會決議通過更換股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2025-11-06-1834-1podgh0","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"18:34:33","subject":"公告本公司董事會通過訂定「114年度員工認股權憑證發行及認股辦法」","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：天良（4127），2025-11-06 18:34，「公告本公司董事會通過訂定「114年度員工認股權憑證發行及認股辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-11-06-1823-10iltaa","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"18:23:17","subject":"董事會決議通過變更111年度現金增資發行新股暨國內第一次無擔保轉換公司債資金運用計畫","clause":"第16款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-11-06 18:23，「董事會決議通過變更111年度現金增資發行新股暨國內第一次無擔保轉換公司債資金運用計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2025-11-06-1821-181moia","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"18:21:16","subject":"公告本公司114年第三季財務報告業經提報董事會通過","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：天良（4127），2025-11-06 18:21，「公告本公司114年第三季財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-11-06-1738-dw6s27","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:38:33","subject":"公告強生化學製藥廠股份有限公司國內第一次無擔保(例：第一次有擔保)轉(交)換公司債(簡稱：強生一，代碼：47471)停止受理轉交換等相關事項。","clause":"第53款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-11-06 17:38，「公告強生化學製藥廠股份有限公司國內第一次無擔保(例：第一次有擔保)轉(交)換公司債(簡稱：強生一，代碼：47471)停止」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-11-06-1728-1t5lupn","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:28:10","subject":"公告本公司董事會決議召開114年股東臨時會日期及相關事宜","clause":"第17款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-11-06 17:28，「公告本公司董事會決議召開114年股東臨時會日期及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-11-06-1725-1kmb7k2","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:25:02","subject":"公告本公司董事會決議以私募方式辦理現金增資發行普通股","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-11-06 17:25，「公告本公司董事會決議以私募方式辦理現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-11-06-1723-y27hiq","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:23:52","subject":"本公司董事會決議發行國內第二次有擔保轉換公司債","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-11-06 17:23，「本公司董事會決議發行國內第二次有擔保轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-11-06-1723-1w5pexy","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:23:04","subject":"公告本公司董事會決議通過擴建產線及增購設備等資本支出預算案","clause":"第15款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-11-06 17:23，「公告本公司董事會決議通過擴建產線及增購設備等資本支出預算案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-11-06-1721-1tyhysh","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:21:57","subject":"公告本公司114年第3季合併財務報告業經提報董事會","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-11-06 17:21，「公告本公司114年第3季合併財務報告業經提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-11-06-1714-xo2pc7","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:14:25","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-11-06 17:14，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-11-06-1713-129cimm","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:13:53","subject":"公告本公司董事會通過114年第3季合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-11-06 17:13，「公告本公司董事會通過114年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-11-06-1713-9dsxs4","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:13:23","subject":"代子公司科進製藥科技股份有限公司公告114年第3季財務報表提報董事會","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-11-06 17:13，「代子公司科進製藥科技股份有限公司公告114年第3季財務報表提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-11-06-1711-1w1a3i9","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"17:11:17","subject":"(更正公告)本公司董事會決議通過股份轉換案與簽署股份轉換契約","clause":"第11款","fact_date":"2025-10-02","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-11-06 17:11，「(更正公告)本公司董事會決議通過股份轉換案與簽署股份轉換契約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-11-06-1711-1vdwe7l","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-11-06","time":"17:11:06","subject":"公告董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第9款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-11-06 17:11，「公告董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-11-06-1657-r3uitn","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:57:36","subject":"公告本公司114年第3季合併財務報告經董事會決議通過","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-11-06 16:57，「公告本公司114年第3季合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2025-11-06-1639-1bea0oa","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:39:52","subject":"公告本公司114年第3季合併財務報告業經董事會決議通過","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2025-11-06 16:39，「公告本公司114年第3季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2025-11-06-1638-isqttc","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:38:29","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2025-11-06 16:38，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-11-06-1638-14o2adr","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-11-06","time":"16:38:10","subject":"本公司董事會決議114年第三季不分派股利","clause":"第14款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-11-06 16:38，「本公司董事會決議114年第三季不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-11-06-1634-1e8va9k","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-11-06","time":"16:34:29","subject":"公告本公司董事會通過114年度第三季合併財務報表","clause":"第43款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-11-06 16:34，「公告本公司董事會通過114年度第三季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-11-06-1634-x3pjnm","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:34:26","subject":"本公司內部稽核主管異動","clause":"第8款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-11-06 16:34，「本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-11-06-1631-160kye0","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:31:46","subject":"代重要子公司BIOTEQUE MEDICAL PHIL. INC.公告董事會通過自地委建倉庫預算案","clause":"第20款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-11-06 16:31，「代重要子公司BIOTEQUE MEDICAL PHIL. INC.公告董事會通過自地委建倉庫預算案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-11-06-1628-1ckd4vq","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-11-06","time":"16:28:37","subject":"公告本公司董事會決議通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-11-06 16:28，「公告本公司董事會決議通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-11-06-1628-1egfkms","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-11-06","time":"16:28:01","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-11-06 16:28，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-11-06-1622-bbt0yl","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:22:03","subject":"本公司將於114年11月18日舉辦上櫃前業績發表會","clause":"第30款","fact_date":"2025-11-18","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-11-06 16:22，「本公司將於114年11月18日舉辦上櫃前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-11-06-1620-1o0y4bi","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:20:12","subject":"補充公告本公司董事會通過藥用軟袋生產設備投資案(追加預算)","clause":"第20款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-11-06 16:20，「補充公告本公司董事會通過藥用軟袋生產設備投資案(追加預算)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-11-06-1616-1a9attw","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:16:36","subject":"董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-11-06 16:16，「董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-11-06-1609-1rk6aod","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:09:21","subject":"公告本公司民國114年度第3季合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-11-06 16:09，「公告本公司民國114年度第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2025-11-06-1603-5np51c","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"16:03:26","subject":"公告本公司114年第3季合併財務報告業經董事會通過","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：精華（1565），2025-11-06 16:03，「公告本公司114年第3季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-11-06-1558-1rai31y","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:58:55","subject":"公告本公司董事會決議擬與璞策國際有限公司簽訂合資協議書及與合資公司之技術授權協議","clause":"第10款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-11-06 15:58，「公告本公司董事會決議擬與璞策國際有限公司簽訂合資協議書及與合資公司之技術授權協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-11-06-1558-1v20vp9","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:58:24","subject":"公告本公司董事會決議辦理現金增資發行新股案","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-11-06 15:58，「公告本公司董事會決議辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-11-06-1558-xppugo","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:58:21","subject":"董事會決議發行員工認股權憑證公告","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-11-06 15:58，「董事會決議發行員工認股權憑證公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-11-06-1557-1xfuutk","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:57:39","subject":"公告本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-11-06 15:57，「公告本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-11-06-1556-1xsycv","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:56:34","subject":"本公司「骨齡輔助評估系統(EFAI BONESUITE XR BONEAGE PRO ASSESSMENT SYSTEM)」獲得馬來西亞MDA上市許可核准","clause":"第53款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-11-06 15:56，「本公司「骨齡輔助評估系統(EFAI BONESUITE XR BONEAGE PRO ASSESSMENT SYSTEM」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-11-06-1556-1tixvya","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:56:03","subject":"本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-11-06 15:56，「本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-11-06-1553-1qj44hg","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:53:18","subject":"公告本公司財務主管異動","clause":"第8款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-11-06 15:53，「公告本公司財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-11-06-1552-isqttc","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-11-06","time":"15:52:39","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-11-06 15:52，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-11-06-1552-l7qirp","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:52:03","subject":"公告本公司會計主管異動","clause":"第8款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-11-06 15:52，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-11-06-1537-1q67uq6","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-11-06","time":"15:37:17","subject":"公告本公司新任集團總裁暨醫療長(CMO)兼美國漢康執行長(CEO)","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-11-06 15:37，「公告本公司新任集團總裁暨醫療長(CMO)兼美國漢康執行長(CEO)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2025-11-06-1529-1tixvya","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2025-11-06","time":"15:29:50","subject":"本公司董事會通過114年第三季合併財務報告","clause":"第43款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2025-11-06 15:29，「本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-11-06-1526-upsw55","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:26:20","subject":"公告本公司114年第3季合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-11-06 15:26，「公告本公司114年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-11-06-1512-182uyqk","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"15:12:23","subject":"公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOATE SALTS」智利專利核准通知書。","clause":"第53款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-11-06 15:12，「公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOA」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-11-06-1503-1ow93j2","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-11-06","time":"15:03:54","subject":"公告本公司董事會通過114年第三季度合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-11-06 15:03，「公告本公司董事會通過114年第三季度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-11-06-1438-1b5d3fa","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"14:38:25","subject":"公告本公司114年第3季財務報告董事會預計召開日期為114年11月14日","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-11-06 14:38，「公告本公司114年第3季財務報告董事會預計召開日期為114年11月14日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-11-06-1428-1v20vp9","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"14:28:53","subject":"公告本公司董事會決議辦理現金增資發行新股案","clause":"第11款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-11-06 14:28，「公告本公司董事會決議辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-11-06-1425-1kwkk2o","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"14:25:09","subject":"本公司董事會決議召開114年第一次股東臨時會相關事宜","clause":"第17款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-11-06 14:25，「本公司董事會決議召開114年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-11-06-1423-1wwvf2x","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"14:23:17","subject":"公告本公司董事會決議通過114年度第3季財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-11-06 14:23，「公告本公司董事會決議通過114年度第3季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-11-06-1423-9ehjdu","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"14:23:05","subject":"公告本公司董事會通過修訂國內第一次無擔保轉換公司債發行 及轉換辦法並辦理債權人公告","clause":"第53款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-11-06 14:23，「公告本公司董事會通過修訂國內第一次無擔保轉換公司債發行 及轉換辦法並辦理債權人公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-11-06-1421-1ckd4vq","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"14:21:16","subject":"公告本公司董事會決議通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-11-06 14:21，「公告本公司董事會決議通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-11-06-1411-1xsnnrl","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-11-06","time":"14:11:37","subject":"公告本公司董事會通過114年第三季度個別財務報告","clause":"第31款","fact_date":"2025-11-06","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-11-06 14:11，「公告本公司董事會通過114年第三季度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}